Kwong, DL, Sham, JS, Au, GK, Chua, DT, Kwong, PW, Cheng, AC
Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. J Clin Oncol
Liu, MT, Hsieh, CY, Chang, TH, Lin, JP, Huang, CC, Wang, AY.
Prognostic factors affecting the outcome of nasopharyngeal carcinoma. Jpn J Clin Oncol
Ponta, H, Sherman, I, Herrlich, PA.
CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol
Goodison, S, Urquidi, V, Tarin, D.
CD44 cell adhesion molecules. Mol Pathol
Kalish, ED, Iida, N, Moffat, FL, Bourguignon, LY.
A new CD44V3-containing isoform is involved in tumor cell growth and migration during human breast carcinoma progression. Front Biosci
Iida, N, Bourguignon, LY.
New CD44 splice variants associated with human breast cancers. J Cell Physiol
Ni, HM, Leong, AF, Cheong, D, Hooi, SC.
Expression of CD44 variants in colorectal carcinoma quantified by real-time reverse transcriptase-polymerase chain reaction. J Lab Clin Med
Kuhn, S, Koch, M, Nübel, T, Ladwein, M, Antolovic, D, Klingbeil, P
A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Mol Cancer Res
Lee, SC, Harn, HJ, Lin, TS, Yeh, KT, Liu, YC, Tsai, CS
Prognostic significance of CD44v5 expression in human thymic epithelial neoplasms. Ann Thorac Surg
Handorean, AM, Yang, K, Robbins, EW, Flaig, TW, Iczkowski, KA.
Silibinin suppresses CD44 expression in prostate cancer cells. Am J Transl Res
Wang, SJ, Wong, G, de Heer, AM, Xia, W, Bourguignon, LY.
CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope
Kunishi, M, Kayada, Y, Yoshiga, K.
Down-regulated expression of CD44 variant 6 in oral squamous cell carcinoma and its relationship to regional lymph node metastasis. Int J Oral Maxillofac Surg
Tsuruoka, S, Matsuo, K, Ishikawa, A, Yamamoto, N, Yamashita, Y, Takahashi, T.
Prognostic significance of CD44v3 and CD44v6 in oral squamous cell carcinoma of the tongue. Oral Med Pathol
Uwa, N, Kataoka, TR, Torii, I, Sato, A, Nishigami, T, Song, M
CD44 expression is related to poor prognosis of hypopharyngeal squamous cell carcinoma. Acta Otolaryngol
R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing
Sobin, LH, Gospodarowicz, MK, Wittekind, C.
TNM Classification of Malignant Tumours. Hoboken, NJ: Wiley-Blackwell, 2009
Bourguignon, LY, Gilad, E, Brightman, A, Diedrich, F, Singleton, P.
Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem
Wang, SJ, Bourguignon, LY.
Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg
Trachootham, D, Alexandre, J, Huang, P.
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Nat Rev Drug Discov
Diehn, M, Cho, RW, Lobo, NA, Kalisky, T, Dorie, MJ, Kulp, AN
Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature
Gottesman, MM, Fojo, T, Bates, SE.
Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer
Prince, ME, Sivanandan, R, Kaczorowski, A, Wolf, GT, Kaplan, MJ, Dalerba, P
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A